From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Surgical Innovations – “confidence that revenues for the year to 31 December 2023 will meet the board's expectations”, but what about the bottom-line?…

By Steve Moore | Wednesday 6 September 2023

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Medical products group Surgical Innovations (SUN) has issued a trading update commencing that “the forward-looking orderbook remains positive, providing confidence that revenues for the year to 31 December 2023 will meet the board's expectations” and also including that measures are being introduced to improve efficiencies and productivity and that reducing inventory in the second half will have a positive impact on cash resources. So what of a share price currently more than 8% lower at 1.65p in response?
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Time left: 22:36:10